Definium Therapeutics (DFTX) Stock Soars to New Heights on Trump’s Psychedelic Research Order

Definium Therapeutics (DFTX) stock surged 13% premarket as Trump's Executive Order accelerates psychedelic drug research for mental health treatment.

The post Definium Therapeutics (DFTX) Stock Soars to New Heights on Trump’s Psychedelic Research Order appeared first on Blockonomi.